Untreated and uncontrolled hypertension in Japanese patients with spontaneous intracerebral hemorrhage
- PMID: 39820067
- DOI: 10.1038/s41440-024-02087-7
Untreated and uncontrolled hypertension in Japanese patients with spontaneous intracerebral hemorrhage
Abstract
Hypertension (HT) is the most attributable and modifiable risk factor for spontaneous intracerebral hemorrhage (SICH). However, epidemiological data on blood pressure (BP) control before SICH and its relationship to patient lifestyles are lacking. This study prospectively enrolled patients with acute SICH from six stroke centers in Tochigi, Japan. BP control and patient lifestyles were investigated using a questionnaire conducted on patients and their families. A total of 365 patients were analyzed, 270 (74.0%) of whom had HT and 198 (54.2%) untreated HT. The prevalence of untreated HT was much higher in younger patients and decreased with age (79.0%, 71.8%, 62.2%, 44.8%, and 31.0% in those aged <50, 50-59, 60-69, 70-79, and ≥80 years, respectively). Patients with untreated HT were significantly less likely have a family doctor and attended fewer annual health checkups than did those with treated or no HT. Untreated HT with awareness was much higher in younger and middle-age men than in women, whereas untreated HT without awareness was much higher in younger women than in men. Among patients who received antihypertensives, the prevalence of well-controlled HT was also very low, especially in younger patients (20.0% and 23.5% in those aged <50, and 50-59 years, respectively). In-hospital mortality was much higher in younger patients (age <70 years) with untreated than with treated or no HT. Untreated and uncontrolled HT were highly detected and seemed to be important targets for the primary prevention of Japanese SICH. Different strategies to improve BP control are warranted for each generation and sex.
Keywords: In-hospital mortality; Lifestyle modification; Spontaneous intracerebral hemorrhage; Uncontrolled hypertension; Untreated hypertension.
© 2025. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: TK received lecture fees from Daiichi-Sankyo Pharmaceutical. KK received a study grants or contracts from Eisai, Daiichi-Sankyo Pharmaceutical, and E.P. medical, consulting fees from Zimmer Biomet, Ono Pharmaceutical, Viatris Pharmaceutical, and IQVIA, and lecture fees and speaker’s fees from Eisai and Daiichi-Sankyo Pharmaceutical. SF received lecture fees and speaker’s fees from Daiichi-Sankyo Pharmaceutical, Bayer Pharmaceutical, Bristol-Myers Squibb, Nippon Boehringer Ingelheim, and Pfizer Japan. RT received lecture fees and speaker’s fees from Nippon Boehringer Ingelheim, Takeda Pharmaceutical, CSL Behring, Eisai, Kowa, Daiichi-Sankyo Pharmaceutical, Kyowa Kirin, Bayer Pharmaceutical, Bristol-Myers Squibb, Otsuka Pharmaceutical, Pfizer Japan, and AbbVie GK.
Comment in
-
The importance of hypertension awareness and adequate blood pressure control before intracerebral hemorrhage.Hypertens Res. 2025 Apr;48(4):1621-1623. doi: 10.1038/s41440-025-02161-8. Epub 2025 Feb 17. Hypertens Res. 2025. PMID: 39962169 No abstract available.
References
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
